DUBLIN--(BUSINESS WIRE)--The "Hematology Analyzers and Reagents Market by Products & Services (Hematology Analyzers (5 Parts, 6 Parts, 3 Part, PoC, Semi-Automated), Hemostasis, Immunohematology), Price Range (High, Low), End User (Government labs) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%.
Technological advancements in hematology analyzers and reagents, integration of flow cytometry techniques with hematology analyzers, and the increasing incidence of blood disorders are the factors expected to drive the market during the study period. However, the high cost of hematology analyzers, product recalls, and slow adoption of advanced hematology instruments in emerging countries are factors restraining the growth of this market to a certain extent.
By price range, the hematology instruments market is segmented into high-end, mid-range, and low-end hematology analyzers. The high-end hematology analyzers segment is expected to register the highest growth during the forecast period. The high growth of this segment is attributed to the reliability, high accuracy, flexibility, ease of use, and multi-parameter testing capabilities of high-end hematology analyzers.
Asia Pacific is expected to register the highest growth rate during the forecast period due to the increasing geriatric population coupled with the growing incidence of thalassemia, sickle cell anemia, and leukemia.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Hematology Analyzers and Reagents Market, By Product & Service
7 Hematology Instruments Market, By Price Range
8 Hematology Products and Services Market, By End User
9 Hematology Analyzers and Reagents Market, By Region
10 Competitive Landscape
11 Company Profiles
- Bio-Rad Laboratories
- Biosystems (A Part of Ginper Group)
- Drew Scientific
- EKF Diagnostics
- Nihon Kohden
- Ortho Clinical Diagnostics
For more information about this report visit https://www.researchandmarkets.com/research/fcpph6/hematology?w=4